China Universal Asset Management Company’s Foghorn Therapeutics FHTX Stock Holding History

China Universal Asset Management Company’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.7K	Buy	10,396 +1,181	+13%	+$6.48K	﹤0.01%	456
2025 Q4	$49.8K	Sell	9,215 -694	-7%	-$3.15K	﹤0.01%	453
2025 Q3	$48.5K	Sell	9,909 -1,286	-11%	-$6.82K	﹤0.01%	434
2025 Q2	$52.6K	Buy	11,195 +40	+0.4%	+$167	0.01%	417
2025 Q1	$40.7K	Sell	11,155 -633	-5%	-$2.89K	﹤0.01%	430
2024 Q4	$55.6K	Buy	+11,788	New	+$85.9K	0.01%	445
2023 Q4	–	Sell	-1,073	Closed	-$5.37K	–	448
2023 Q3	$5.37K	Buy	1,073 +525	+96%	+$4.05K	﹤0.01%	383
2023 Q2	$3.86K	Sell	548 -18	-3%	-$126	﹤0.01%	392
2023 Q1	$3.51K	Buy	566 +141	+33%	+$923	﹤0.01%	403
2022 Q4	$2.71K	Buy	+425	New	+$3.21K	﹤0.01%	354

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

China Universal Asset Management Company's FHTX Position: Q1 2026 in Review

China Universal Asset Management Company increased its Foghorn Therapeutics (FHTX) stake by 13% in Q1 2026, buying an estimated $6.48K and bringing the position to 10,396 shares worth $49.7K. The position accounts for ﹤0.01% of the portfolio, ranked #456.

China Universal Asset Management Company first reported a position in FHTX in Q4 2022 and has held it in 10 quarters since. The position peaked at $55.6K in Q4 2024. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

China Universal Asset Management Company held 10,396 shares of Foghorn Therapeutics worth $49.7K as of Q1 2026.
China Universal Asset Management Company bought 1,181 Foghorn Therapeutics shares in Q1 2026, an estimated $6.48K.
Foghorn Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #456 holding.
China Universal Asset Management Company first reported a position in Foghorn Therapeutics in Q4 2022 and has held it in 10 quarters since.
China Universal Asset Management Company's Foghorn Therapeutics position peaked at $55.6K in Q4 2024.
105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.